Global In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Forecast 2024-2030- Product Image

Sale

Global In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 5925152

UP TO €850EUR$875USD£726GBP OFF until Dec 31^st 2024

The In-Silico Drug Discovery Market size was estimated at USD 2.69 billion in 2023, USD 2.86 billion in 2024, and is expected to grow at a CAGR of 8.71% to reach USD 4.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Silico Drug Discovery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Silico Drug Discovery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Silico Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abzena Ltd., Aragen Life Sciences Pvt. Ltd., BioDuro LLC, BioNTech SE, Certara, Inc., Charles River Laboratories International, Inc., Chemical Computing Group ULC, ChemPartner PharmaTech Co Ltd, Creative Biostructure, Curia Global Inc., Evotec SE, GenScript Biotech Corporation, InSilico Medicine, Ligand Pharmaceuticals Incorporated, Schrödinger Inc., Selvita S.A., Simulations Plus, Inc., Sygnature Discovery, Viva Biotech Holding Group, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Silico Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Molecule Type
- Antibodies
- Nucleic Acids
- Peptides
- Proteins
- Vectors
Workflow
- Bioinformatics
- Clinical Trials
- Discovery
- Preclinical Tests
- Protein Structure Prediction
- Reverse Docking
- Target Identification
Therapeutic Area
- Blood Disorders
- Infectious Diseases
- Mental Disorders
- Metabolic Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
- Skin Disorders
End User
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical Manufacturers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the In-Silico Drug Discovery Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Silico Drug Discovery Market?
What are the technology trends and regulatory frameworks in the In-Silico Drug Discovery Market?
What is the market share of the leading vendors in the In-Silico Drug Discovery Market?
Which modes and strategic moves are suitable for entering the In-Silico Drug Discovery Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. In-Silico Drug Discovery Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diseases and increase in drug discovery
5.1.1.2. Improvement in computational models and simulations
5.1.1.3. Inclination towards personalized medicine approach
5.1.2. Restraints
5.1.2.1. Concerns associated with data integration
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in in-silico drug discovery
5.1.3.2. Ongoing R&D to drive innovation in in-silico drug discovery
5.1.4. Challenges
5.1.4.1. Complex process and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. In-Silico Drug Discovery Market, by Molecule Type

6.1. Introduction
6.2. Antibodies
6.3. Nucleic Acids
6.4. Peptides
6.5. Proteins
6.6. Vectors

7. In-Silico Drug Discovery Market, by Workflow

7.1. Introduction
7.2. Bioinformatics
7.3. Clinical Trials
7.4. Discovery
7.5. Preclinical Tests
7.6. Protein Structure Prediction
7.7. Reverse Docking
7.8. Target Identification

8. In-Silico Drug Discovery Market, by Therapeutic Area

8.1. Introduction
8.2. Blood Disorders
8.3. Infectious Diseases
8.4. Mental Disorders
8.5. Metabolic Disorders
8.6. Musculoskeletal Disorders
8.7. Neurological Disorders
8.8. Oncological Disorders
8.9. Respiratory Disorders
8.10. Skin Disorders

9. In-Silico Drug Discovery Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical Manufacturers

10. Americas In-Silico Drug Discovery Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific In-Silico Drug Discovery Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa In-Silico Drug Discovery Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abzena Ltd.
14.1.2. Aragen Life Sciences Pvt. Ltd.
14.1.3. BioDuro LLC
14.1.4. BioNTech SE
14.1.5. Certara, Inc.
14.1.6. Charles River Laboratories International, Inc.
14.1.7. Chemical Computing Group ULC
14.1.8. ChemPartner PharmaTech Co Ltd
14.1.9. Creative Biostructure
14.1.10. Curia Global Inc.
14.1.11. Evotec SE
14.1.12. GenScript Biotech Corporation
14.1.13. InSilico Medicine
14.1.14. Ligand Pharmaceuticals Incorporated
14.1.15. Schrödinger Inc.
14.1.16. Selvita S.A.
14.1.17. Simulations Plus, Inc.
14.1.18. Sygnature Discovery
14.1.19. Viva Biotech Holding Group
14.1.20. WuXi AppTec
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. IN-SILICO DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IN-SILICO DRUG DISCOVERY MARKET DYNAMICS
FIGURE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IN-SILICO DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 6. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REVERSE DOCKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 20. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 48. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 52. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 70. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 74. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 82. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 106. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 111. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 118. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 119. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 120. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 122. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 123. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 127. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 131. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 132. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 135. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 143. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 155. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 159. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 179. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 190. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 191. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 192. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 202. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 203. IN-SILICO DRUG DISCOVERY MARKET LICENSE & PRICING

Companies Mentioned

Abzena Ltd.
Aragen Life Sciences Pvt. Ltd.
BioDuro LLC
BioNTech SE
Certara, Inc.
Charles River Laboratories International, Inc.
Chemical Computing Group ULC
ChemPartner PharmaTech Co Ltd
Creative Biostructure
Curia Global Inc.
Evotec SE
GenScript Biotech Corporation
InSilico Medicine
Ligand Pharmaceuticals Incorporated
Schrödinger Inc.
Selvita S.A.
Simulations Plus, Inc.
Sygnature Discovery
Viva Biotech Holding Group
WuXi AppTec

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.86 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.83 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	20

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,800GBP €3641EUR$3,749USD£3,111GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,546GBP €4612EUR$4,749USD£3,941GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,293GBP €5584EUR$5,749USD£4,770GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5899EUR$6,074USD£5,040GBP €6555EUR$6,749USD£5,600GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,534GBP €8497EUR$8,749USD£7,260GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2030

In Silico Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Workflow, By Software Type, By Technology, By Therapeutic Area, By End User, By Company and By Region

In Silico Drug Design. Repurposing Techniques and Methodologies

Toxicology Drug Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Nanotechnology and In Silico Tools. Natural Remedies and Drug Discovery. Drug Discovery Update

About the In Silico Drug Discovery Market